Day: Vigeneron
ecosystem
Gene therapy startup Vigeneron begins phase I clinical trial
The hereditary disease retinitis pigmentosa is one of the most common causes of vision loss in middle adulthood. Currently incurable,...
DE
Translations are powered by AI
